For Patients


Read More

Events


Read More

Project

Context

Hepatitis B virus (HBV) is a major global public health threat with over 257 million people worldwide.


Read More

Strategy

Stimulating innate signaling and inhibiting viral replication in infected hepatocytes.


Read More

Objectives

Perform a proof of concept clinical trial to evaluate novel immune modulators and their combination to boost...


Read More

Expected Results

Improve the functional cure rate in « CHB » Chronic Hepatitis B and provide opportunities for finite duration curing therapies...


Read More

Outcomes for medical experts

Outcomes for patient


Outcomes for community

IP-cure-B in numbers

Don't hesitate to contact us!


    CONTACT US